H33.0 H25.1
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Stable and attached retina 3-6 months after vitrectomy. - BCVA between 0.3 and 0.7 LogMAR - The patient must sign a written declaration of consent before being included in the study. - For patients with successful retinal detachment surgery in both eyes, only the first eye will be considered for the primary endpoint. *The operation is defined as successful if functional and anatomical success can only be determined after an operation 3-6 months later
Exclusion criteria
Exclusion criteria: - High ammetropia (21 = AL = 28.5mm) - High corneal astigmatism (>3D) or other corneal pathology - Patients with macular involvement who were not treated within 3 days - Epiretinal macular membrane stage 3 and 4 (Govetto stage) - Glaucoma - Uveitis - History of retinal vascular occlusion - History of anti-VEGF therapy - Severe disintegration of the retinal layers (outer retinal layers) - Reduced retinal thickness compared to the fellow eye on OCT - History of ocular trauma.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary study outcome was monocular CDVA at 6 months after cataract surgery of primary eye. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes included refractive outcome, CIVA, CNVA, UDVA, UIVA, UNVA, binocular UDVA, UIVA and UNVA. Explorative parameters included defocus curve, patient satisfaction, and halos/glare results. | — |
Countries
Germany
Contacts
Augenklinik